Celcuity(CELC) - 2024 Q1 - Quarterly Results

First Quarter 2024 Financial Results Exhibit 99.1 Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update MINNEAPOLIS, May 15, 2024 — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the first quarter ended March 31, 2024 and other recent business developments. "We continued to execute well this quarter. Our VIKTORIA-1 study remains on-track, and we dosed the first p ...